Publications by authors named "Ulrich Feige"

Claim this Profile
R
Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy.
Brad Bolon, Marina Stolina, Caroline King, Scot Middleton, Jill Gasser, Ulrich Feige

J Biomed Biotechnol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.
Marina Stolina, Georg Schett, Denise Dwyer, Steven Vonderfecht, Scot Middleton, Ulrich Feige

Arthritis Res Ther· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis.
Georg Schett, Marina Stolina, Denise Dwyer, Debra Zack, Stefan Uderhardt, Ulrich Feige

Arthritis Rheum· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritis.
Marina Stolina, Brad Bolon, Scot Middleton, Denise Dwyer, Heather Brown, Ulrich Feige

J Clin Immunol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
Esther Furrer, Marianne Berdugo, Cinzia Stella, Francine Behar-Cohen, Robert Gurny, Ulrich Feige

Invest Ophthalmol Vis Sci· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient intraocular penetration of topical anti-TNF-alpha single-chain antibody (ESBA105) to anterior and posterior segment without penetration enhancer.
Michael Ottiger, Michael A Thiel, Ulrich Feige, Peter Lichtlen, David M Urech

Invest Ophthalmol Vis Sci· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving systemic and local biomarker milieu at different stages of disease progression in rat collagen-induced arthritis.
Marina Stolina, Brad Bolon, Denise Dwyer, Scot Middleton, Diane Duryea, Ulrich Feige

Biomarkers· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis.
Marina Stolina, Stephen Adamu, Mike Ominsky, Denise Dwyer, Frank Asuncion, Ulrich Feige

J Bone Miner Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the kinetics of osteoclastogenesis in arthritic rats.
Georg Schett, Marina Stolina, Brad Bolon, Scot Middleton, Matt Adlam, Ulrich Feige

Arthritis Rheum· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis: a role for the tumor necrosis factor signaling axis.
Elizabeth C Wahl, Daniel S Perrien, James Aronson, Zhendong Liu, Terry W Fletcher, Ulrich Feige

Alcohol Clin Exp Res· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models.
Georg Schett, Scot Middleton, Brad Bolon, Marina Stolina, Heather Brown, Ulrich Feige

Arthritis Rheum· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
Masahiko Kobayashi, Ginette R Squires, Aisha Mousa, Michael Tanzer, David J Zukor, Ulrich Feige

Arthritis Rheum· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-1 and TNF antagonists prevent inhibition of fracture healing by ethanol in rats.
Daniel S Perrien, Elizabeth C Wahl, William R Hogue, Ulrich Feige, James Aronson

Toxicol Sci· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Jochen Zwerina, Silvia Hayer, Makiyeh Tohidast-Akrad, Helga Bergmeister, Kurt Redlich, Ulrich Feige

Arthritis Rheum· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseases.
Carl K Edwards, Steven W Martin, James Seely, Olaf Kinstler, Scott Buckel, Ulrich Feige

Adv Drug Deliv Rev· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-1 and tumor necrosis factor antagonists attenuate ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis.
Daniel S Perrien, Elizabeth C Brown, Terry W Fletcher, David J Irby, James Aronson, Ulrich Feige

J Pharmacol Exp Ther· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis.
Brad Bolon, Victoria Shalhoub, Paul J Kostenuik, Giuseppe Campagnuolo, Sean Morony, Ulrich Feige

Arthritis Rheum· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis.
Angela Coxon, Brad Bolon, Juan Estrada, Stephen Kaufman, Sheila Scully, Ulrich Feige

Arthritis Rheum· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis.
Giuseppe Campagnuolo, Brad Bolon, Ulrich Feige

Arthritis Rheum· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis